Literature DB >> 2744714

Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors.

M H Shiu1, M Perrotti, M F Brennan.   

Abstract

We performed a retrospective prognostic study of 246 patients treated for adenocarcinoma of the stomach with curative intent over the period 1960-1984. Lesions of the cardia and gastro-esophageal junction were excluded. The study examined the prognostic influence of nine clinicopathologic and six treatment variables by univariate and multivariate analysis. Five-year survival rates (Kaplan-Meier) for TNM stages, IA, IB, II, IIIA, and IIIB were 88%, 80%, 55%, 30% and 9%, respectively. The Cox models of proportional hazards identified five independent variables predictive of death from gastric cancer: high TNM stage, metastatic involvement of four or more regional lymph nodes, poor differentiation of tumor, splenectomy and insufficient scope of regional lymph-adenectomy relative to the nodal stage (R minus N less than 1.5).

Entities:  

Mesh:

Year:  1989        PMID: 2744714

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  24 in total

1.  Prognostic analysis in node-negative gastric cancer patients in China.

Authors:  Miao-zhen Qiu; Zhi-qiang Wang; Hui-yan Luo; Dong-sheng Zhang; Zhi-wei Zhou; Yu-hong Li; Wen-qi Jiang; Rui-hua Xu
Journal:  Tumour Biol       Date:  2010-12-22

2.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

3.  Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.

Authors:  Alexander R Novotny; Christoph Schuhmacher; Raymonde Busch; Michael W Kattan; Murray F Brennan; Jörg Rüdiger Siewert
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

4.  Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach.

Authors:  C W Wu; M C Hsieh; S S Lo; S H Tsay; A F Li; W Y Lui; F K P'eng
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

5.  [Multivisceral resection of advanced stomach cancer].

Authors:  C Gebhardt; K H Schultheis
Journal:  Langenbecks Arch Chir       Date:  1993

6.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

7.  Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy.

Authors:  Chun-Nan Yeh; Shih-Ming Jung; Tsung-Wen Chen; Tsann-Long Hwang; Yi-Yin Jan; Miin-Fu Chen
Journal:  Langenbecks Arch Surg       Date:  2009-12-10       Impact factor: 3.445

8.  Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis.

Authors:  Kun Yang; Xin-Zu Chen; Jian-Kun Hu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

9.  Gastric cancer: a curable disease in Britain.

Authors:  H M Sue-Ling; D Johnston; I G Martin; M F Dixon; M R Lansdown; M J McMahon; A T Axon
Journal:  BMJ       Date:  1993-09-04

10.  Comparison of colorectal and gastric cancer: survival and prognostic factors.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.